MedTrace Logo

Home-Administered Trial of Direct Current Stimulation

NCT02894736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2018-08-02

No results posted yet for this study

Summary

Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.

Conditions

Interventions

DEVICE

Soterix tDCS machine

Soterix tDCS machine - miniCT supervised neuromodulation system

Sponsors & Collaborators

  • The University of New South Wales

    lead OTHER

Principal Investigators

  • Angelo Alonzo, BSc(Hons)/BA, PhD · University of New South Wales / Black Dog Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-03-31
Completion
2018-07-31

Countries

  • Australia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02894736 on ClinicalTrials.gov